Y020-2603 Screening compound: 1-(2-methyl-1H-indol-3-yl)-2-phenyl-2-[4-(pyrimidin-2-yl)piperazin-1-yl]ethan-1-one

Y020-2603 Screening compound: 1-(2-methyl-1H-indol-3-yl)-2-phenyl-2-[4-(pyrimidin-2-yl)piperazin-1-yl]ethan-1-one
Y020-2603 Screening compound: 1-(2-methyl-1H-indol-3-yl)-2-phenyl-2-[4-(pyrimidin-2-yl)piperazin-1-yl]ethan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound Y020-2603
1-(2-methyl-1H-indol-3-yl)-2-phenyl-2-[4-(pyrimidin-2-yl)piperazin-1-yl]ethan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y020-2603

Molecular Formula

C25H25N5O (C25 H25 N5 O)

Compound Name

1-(2-methyl-1H-indol-3-yl)-2-phenyl-2-[4-(pyrimidin-2-yl)piperazin-1-yl]ethan-1-one

IUPAC name

1-(2-methyl-1H-indol-3-yl)-2-phenyl-2-[4-(pyrimidin-2-yl)piperazin-1-yl]ethan-1-one

SMILES

Cc1c(C(C(c2ccccc2)N(CC2)CCN2c2ncccn2)=O)c(cccc2)c2[nH]1

InChI

InChI=1S/C25H25N5O/c1-18-22(20-10-5-6-11-21(20)28-18)24(31)23(19-8-3-2-4-9-19)29-14-16-30(17-15-29)25-26-12-7-13-27-25/h2-13,23,28H,14-17H2,1H3/t23-/m1/s1

InChI Key

ZNJKCAANMRNLGP-HSZRJFAPSA-N

MDL Number (MFCD)

MFCD08132934

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

411.51

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.410

Distribution Coefficient, logD

4.405

Water Solubility, LogSw

-4.39

Polar Surface Area

48.279

Acid Dissociation Constant (pKa)

16.13

Base Dissociation Constant (pKb)

5.53

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

24.00

Y020-2603 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

Indole Derivatives (10091 compounds)

SmartTM Library (51161 compounds)

Akt-Targeted Library (14764 compounds)

Ion Channels Focused Library (26372 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Nervous system
  • Cardiovascular
Structure:
  • Cyclic compounds
Targets:
  • Kinases
  • Ion Channels

References: we are preparing a list of scientific research reports with Y020-2603 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y020-2603?
Check Price and Availability of Y020-2603, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y020-2603 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y020-2603
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y020-2603
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y020-2603 available by request